Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults
- PMID: 22990274
- PMCID: PMC3556508
- DOI: 10.1001/2012.jama.11132
Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults
Abstract
Context: The risk of type 2 diabetes mellitus is heterogeneous among obese individuals. Factors that discriminate prediabetes or diabetes risk within this population have not been well characterized. A dysfunctional adiposity phenotype, characterized by excess visceral fat and insulin resistance, may contribute to diabetes development in those with obesity.
Objective: To investigate associations between adiposity phenotypes and risk for incident prediabetes and diabetes in a multiethnic, population-based cohort of obese adults.
Design, setting, and participants: Among 732 obese participants (body mass index ≥30) aged 30 to 65 years without diabetes or cardiovascular disease enrolled between 2000 and 2002 in the Dallas Heart Study, we measured body composition by dual energy x-ray absorptiometry and magnetic resonance imaging (MRI); circulating adipokines and biomarkers of insulin resistance, dyslipidemia, and inflammation; and subclinical atherosclerosis and cardiac structure and function by computed tomography and MRI.
Main outcome measures: Incidence of diabetes through a median 7.0 years (interquartile range, 6.6-7.6) of follow-up. In a subgroup of 512 participants with normal fasting glucose values at baseline, incidence of the composite of prediabetes or diabetes was determined.
Results: Of the 732 participants (mean age, 43 years; 65% women; 71% nonwhite), 84 (11.5%) developed diabetes. In multivariable analysis, higher baseline visceral fat mass (odds ratio [OR] per 1 SD [1.4 kg], 2.4; 95% CI, 1.6-3.7), fructosamine level (OR per 1 SD [1.1 μmol/L], 2.0; 95% CI, 1.4-2.7), fasting glucose level (OR per 1 SD [1.1 μmol/L], 1.9; 95% CI, 1.4-2.6), family history of diabetes (OR, 2.3; 95% CI, 1.3-4.3), systolic blood pressure (OR per 10 mm Hg, 1.3; 95% CI, 1.1-1.5), and weight gain over follow-up (OR per 1 kg, 1.06; 95% CI, 1.02-1.10) were independently associated with diabetes, with no associations observed for body mass index, total body fat, or abdominal subcutaneous fat. Among the 512 participants with normal baseline glucose values, the composite outcome of prediabetes or diabetes occurred in 39.1% and was independently associated with baseline measurements of visceral fat mass; levels of fasting glucose, insulin, and fructosamine; older age; nonwhite race; family history of diabetes; and weight gain over follow-up (P < .05 for each) but not with measurements of general adiposity.
Conclusion: Excess visceral fat and insulin resistance, but not general adiposity, were independently associated with incident prediabetes and type 2 diabetes mellitus in obese adults.
Conflict of interest statement
Figures


Comment in
-
Measures of adiposity and fat distribution and risk of diabetes.JAMA. 2013 Jan 23;309(4):339-40. doi: 10.1001/jama.2012.94335. JAMA. 2013. PMID: 23340625 No abstract available.
-
Measures of adiposity and fat distribution and risk of diabetes--reply.JAMA. 2013 Jan 23;309(4):340. doi: 10.1001/jama.2012.94338. JAMA. 2013. PMID: 23340626 No abstract available.
Similar articles
-
Individual and combined effects of muscle strength and visceral adiposity on incident prediabetes and type 2 diabetes in a longitudinal cohort of midlife Asian women.Diabetes Obes Metab. 2025 Jan;27(1):155-164. doi: 10.1111/dom.15995. Epub 2024 Oct 4. Diabetes Obes Metab. 2025. PMID: 39364654
-
Adiposity modifies the association between heart failure risk and glucose metabolic disorder in older individuals: a community-based prospective cohort study.Cardiovasc Diabetol. 2024 Aug 27;23(1):318. doi: 10.1186/s12933-024-02418-5. Cardiovasc Diabetol. 2024. PMID: 39192249 Free PMC article.
-
Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.Diabetologia. 2018 Dec;61(12):2570-2579. doi: 10.1007/s00125-018-4720-1. Epub 2018 Aug 29. Diabetologia. 2018. PMID: 30159588 Free PMC article.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Excess body fat in obese and normal-weight subjects.Nutr Res Rev. 2012 Jun;25(1):150-61. doi: 10.1017/S0954422412000054. Epub 2012 May 25. Nutr Res Rev. 2012. PMID: 22625426 Review.
Cited by
-
Identification of sex-specific thresholds for accumulation of visceral adipose tissue in adults.Obesity (Silver Spring). 2015 Feb;23(2):375-82. doi: 10.1002/oby.20961. Epub 2014 Dec 31. Obesity (Silver Spring). 2015. PMID: 25627625 Free PMC article.
-
Impact of CPAP treatment for obstructive sleep apnea on visceral adipose tissue: a meta-analysis of randomized controlled trials.Sleep Breath. 2021 Jun;25(2):555-562. doi: 10.1007/s11325-020-02181-3. Epub 2020 Aug 28. Sleep Breath. 2021. PMID: 32857319 Review.
-
Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.J Am Coll Cardiol. 2013 Aug 20;62(8):752-60. doi: 10.1016/j.jacc.2013.03.038. Epub 2013 Apr 16. J Am Coll Cardiol. 2013. PMID: 23602771 Free PMC article.
-
Novel genes underlying beta cell survival in metabolic stress.Bioinformation. 2013;9(1):37-41. doi: 10.6026/97320630009037. Epub 2013 Jan 9. Bioinformation. 2013. PMID: 23390342 Free PMC article.
-
Decrease in the Size of Fat-Enlarged Axillary Lymph Nodes and Serum Lipids after Bariatric Surgery.Cells. 2022 Jan 30;11(3):482. doi: 10.3390/cells11030482. Cells. 2022. PMID: 35159291 Free PMC article.
References
-
- Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–241. - PubMed
-
- Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D’Agostino RB., Sr Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation. 2006;113 (25):2914–2918. - PubMed
-
- Wijeysundera HC, Machado M, Farahati F, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005. JAMA. 2010;303(18):1841–1847. - PubMed
-
- Garber AJ, Handelsman Y, Einhorn D, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? a consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008;14(7):933–946. - PubMed
-
- Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation. 2007;116(2):151–157. - PubMed